Skip to main navigation

    North America

    • United States
      • English
    • Canada
      • English
      • Français
  • Investors
    • Events & Presentations
    • Financials & Filings
    • Stock Information
    • Investor FAQs
    • Contact Us
  • Newsroom
  • Careers
    • Job Openings

    North America

    • United States
      • English
    • Canada
      • English
      • Français
  • Areas of Focus
    • Cardiometabolic
    • Hypertriglyceridemia
    • Dyslipidemia
    • Cardiovascular Disease
    • Pulmonary
    • Inflammatory Pulmonary Diseases
    • Muco-obstructive
    • Idiopathic Pulmonary Fibrosis
  • Our Medicines
  • Pipeline
  • Science & Innovation
    • Partnerships
    • Publications
    • Clinical Trials
  • Patients & Caregivers
    • What is RNAi?
    • Patient Centricity & Advocacy
    • Patient Stories
    • FCS Patient Insights
    • Expanded Access Programs
  • About
    • Leadership Team
    • Corporate Governance
  • Investors
    • Events & Presentations
    • Financials & Filings
    • Stock Information
    • Investor FAQs
    • Contact Us
  • Newsroom
  • Careers
    • Job Openings
Banner Image Banner Image

Financials & Filings

Home / Investors /

Financials & Filings

  • SEC Filings
  • Annual Reports
  • Quarterly Results
  • Key Ratios
Show all

2026

First Quarter
  • Arrowhead Pharmaceuticals 2026 First Quarter Results
  • Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results
  • Form 10-Q

Proxy Statements

Filing Date View
Jan 27, 2026
0000879407-26-000019.pdf
0000879407-26-000019.rtf
0000879407-26-000019.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Jan 29, 2025
0001628280-25-002848.pdf
0001628280-25-002848.rtf
0001628280-25-002848.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Form 10-K

Filing Date View
Nov 25, 2025
View HTML
0000879407-25-000029.pdf
0000879407-25-000029.rtf
0000879407-25-000029.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 26, 2024
View HTML
0001628280-24-049277.pdf
0001628280-24-049277.rtf
0001628280-24-049277.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Form 10-Q

Filing Date View
May 07, 2026
0000879407-26-000047.pdf
0000879407-26-000047.rtf
0000879407-26-000047.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Feb 05, 2026
0000879407-26-000034.pdf
0000879407-26-000034.rtf
0000879407-26-000034.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
  • Email Alerts
  • Download Library
  • RSS Feeds
  • Print Page
  • Search Investors

Footer Navigation

  • Areas of Focus
  • Our Medicines
  • Pipeline
  • Science & Innovation
  • Patients & Caregivers
  • About
  • Twitter
  • LinkedIn
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Sitemap
  • Contact Us
  • Safety Reporting

Copyright © Arrowhead Pharmaceuticals Inc.